Mateusz Tajstra

Mateusz Tajstra

Auto-generated profile, based on publicly available information

Mateusz Tajstra

3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia , Katowice

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MGMariusz Gąsior
Mariusz Gąsior
MZMichael Oscar Zembala
Michael Oscar Zembala
MTMateusz Tajstra
Mateusz Tajstra
KFKrzysztof Filipiak
Krzysztof Filipiak
MGMarek Gierlotka
Marek Gierlotka
MZMarian Zembala
Marian Zembala

1 May 2018 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MTMateusz Tajstra
Mateusz Tajstra
THTomasz Hrapkowicz
Tomasz Hrapkowicz
MHMichał Hawranek
Michał Hawranek
KFKrzysztof Filipiak
Krzysztof Filipiak
MGMarek Gierlotka
Marek Gierlotka
MZMichael Oscar Zembala
Michael Oscar Zembala

1 September 2016 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MTMateusz Tajstra
Mateusz Tajstra
ŁPŁukasz Pyka
Łukasz Pyka
JGJarosław Gorol
Jarosław Gorol
DPDamian Pres
Damian Pres
MGMarek Gierlotka
Marek Gierlotka
MGMariusz Gąsior
Mariusz Gąsior

1 January 2012 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MTMateusz Tajstra
Mateusz Tajstra
MGMariusz Gasior
Mariusz Gasior
MGMarek Gierlotka
Marek Gierlotka
DPDamian Pres
Damian Pres
MHMichał Hawranek
Michał Hawranek
MZMarian Zembala
Marian Zembala

1 May 2021 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MTMateusz Tajstra
Mateusz Tajstra
JJJerzy Jaroszewicz
Jerzy Jaroszewicz
MGMariusz Gąsior
Mariusz Gąsior

18 April 2020 in EP Europace
Verified
Journal Article
Closed access
MTMateusz Tajstra
Mateusz Tajstra
ASAdam Sokal
Adam Sokal
EGElżbieta Gadula-Gacek
Elżbieta Gadula-Gacek
AKAnna Kurek
Anna Kurek
AWAleksandra Wozniak
Aleksandra Wozniak
MGMariusz Gasior
Mariusz Gasior
Aims: The number of patients with heart failure (HF) and implantable cardiac electronic devices has been growing steadily. Remote monitoring care (RC) of cardiac implantable electronic devices can facilitate patient-healthcare clinical interactions and prompt preventive activities to improve HF outcomes. However, studies that have investigated the efficacy of remote monitoring have shown mixed findings, with better results for the system including daily verification of transmission. The purpose of the RESULT study was to analyse the impact of remote monitoring on clinical outcomes in HF patients with implantable cardioverter-defibrillator [ICD/cardiac resynchronization therapy-defibrillator (CRT-D)] in real-life conditions. Methods and results: The RESULT is a prospective, single-centre, randomized trial. Patients with HF and de novo ICD or CRT-D implantation were randomized to undergo RC vs. in-office follow-ups (SC, standard care). The primary endpoint was a composite of all-cause death and hospitalization due to cardiovascular reasons within 12 months after randomization. We randomly assigned 600 eligible patients (299 in RC vs. 301 in SC). Baseline clinical and echocardiographic characteristics were well-balanced and similar in both arms. The incidence of the primary endpoint differed significantly between RC and SC and involved 39.5% and 48.5% of patients, respectively, (P = 0.048) within the 12-month follow-up. The rate of all-cause mortality was similar between the studied groups (6% vs. 6%, P = 0.9), whereas hospitalization rate due to cardiovascular reasons was higher in SC (37.1% vs. 45.5%, P = 0.045). Conclusion: Remote monitoring of HF patients with implanted ICD or CRT-D significantly reduced the primary endpoint rate, mostly as a result of a lower hospitalization rate in the RC arm (ClinicalTrials.gov Identifier: NCT02409225).